{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:21:56Z","timestamp":1792552916615,"version":"4.5.0"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-026-01464-4","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:47:02Z","timestamp":1778719622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Circadian engineering of in vivo CAR T cell therapy for precision oncology"],"prefix":"10.1038","volume":"10","author":[{"given":"Jhommara","family":"Bautista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina E.","family":"Echeverr\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Gabriella","family":"Rodr\u00edguez-Marcano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"L\u00f3pez-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"1464_CR1","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nrg.2016.150","volume":"18","author":"JS Takahashi","year":"2017","unstructured":"Takahashi, J. S. Transcriptional architecture of the mammalian circadian clock. Nat. Rev. Genet. 18, 164\u2013179 (2017).","journal-title":"Nat. Rev. Genet."},{"key":"1464_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39401-1","volume":"13","author":"A P\u00e9rez-Villa","year":"2023","unstructured":"P\u00e9rez-Villa, A. et al. Integrated multi-omics analysis reveals the molecular interplay between circadian clocks and cancer pathogenesis. Sci. Rep. 13, 14198 (2023).","journal-title":"Sci. Rep."},{"key":"1464_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev-immunol-090122-050842","volume":"42","author":"R Pick","year":"2024","unstructured":"Pick, R., Wang, C., Zeng, Q., G\u00fcl, Z. M. & Scheiermann, C. Circadian rhythms in anticancer immunity: mechanisms and treatment opportunities. Annu. Rev. Immunol. 42, 83\u2013102 (2024).","journal-title":"Annu. Rev. Immunol."},{"key":"1464_CR4","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.tcb.2021.06.008","volume":"31","author":"W Xuan","year":"2021","unstructured":"Xuan, W. et al. Circadian regulation of cancer cell and tumor microenvironment crosstalk. Trends Cell Biol. 31, 940\u2013950 (2021).","journal-title":"Trends Cell Biol."},{"key":"1464_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nri3386","volume":"13","author":"C Scheiermann","year":"2013","unstructured":"Scheiermann, C., Kunisaki, Y. & Frenette, P. S. Circadian control of the immune system. Nat. Rev. Immunol. 13, 190\u2013198 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"1464_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41571-023-00754-1","volume":"20","author":"KM Cappell","year":"2023","unstructured":"Cappell, K. M. & Kochenderfer, J. N. Long-term outcomes following CAR T cell therapy: what we know so far. Nat. Rev. Clin. Oncol. 20, 359\u2013371 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1464_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41409-024-02429-6","volume":"60","author":"A Rampotas","year":"2025","unstructured":"Rampotas, A., Richter, J., Isenberg, D. & Roddie, C. CAR-T cell therapy embarks on autoimmune disease. Bone Marrow Transpl. 60, 6\u20139 (2025).","journal-title":"Bone Marrow Transpl."},{"key":"1464_CR8","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1126\/science.ads8473","volume":"388","author":"TL Hunter","year":"2025","unstructured":"Hunter, T. L. et al. In vivo CAR T cell generation to treat cancer and autoimmune disease. Science 388, 1311\u20131317 (2025).","journal-title":"Science"},{"key":"1464_CR9","doi-asserted-by":"publisher","first-page":"102220","DOI":"10.1016\/j.esmoop.2023.102220","volume":"9","author":"T Landr\u00e9","year":"2024","unstructured":"Landr\u00e9, T. et al. Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis. ESMO Open 9, 102220 (2024).","journal-title":"ESMO Open"},{"key":"1464_CR10","doi-asserted-by":"publisher","first-page":"105395","DOI":"10.1016\/j.ebiom.2024.105395","volume":"109","author":"M Quist","year":"2024","unstructured":"Quist, M., van Os, M., van Laake, L. W., Bovenschen, N. & Crnko, S. Integration of circadian rhythms and immunotherapy for enhanced precision in brain cancer treatment. EBioMedicine. 109, 105395 (2024).","journal-title":"EBioMedicine."},{"key":"1464_CR11","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1158\/0008-5472.CAN-24-2083","volume":"84","author":"CL Wang","year":"2024","unstructured":"Wang, C. L., Zhang, X. & Dang, C. V. Clocking cancer immunotherapy responses. Cancer Res 84, 2756\u20132758 (2024).","journal-title":"Cancer Res"},{"key":"1464_CR12","first-page":"e82994","volume":"17","author":"S Nagy","year":"2025","unstructured":"Nagy, S., Hussein, A. & Kesselman, M. M. The importance of timing in immunotherapy: A systematic review. Cureus 17, e82994 (2025).","journal-title":"Cureus"},{"key":"1464_CR13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s12672-024-01643-4","volume":"15","author":"M El-Tanani","year":"2024","unstructured":"El-Tanani, M. et al. Circadian rhythms and cancer: implications for timing in therapy. Discov. Oncol. 15, 767 (2024).","journal-title":"Discov. Oncol."},{"key":"1464_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41573-025-01291-5","volume":"25","author":"A Bot","year":"2026","unstructured":"Bot, A. et al. In vivo chimeric antigen receptor (CAR)-T cell therapy. Nat. Rev. Drug Discov. 25, 116\u2013137 (2026).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1464_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19486-2","volume":"11","author":"NN Parayath","year":"2020","unstructured":"Parayath, N. N., Stephan, S. B., Koehne, A. L., Nelson, P. S. & Stephan, M. T. In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo. Nat. Commun. 11, 6080 (2020).","journal-title":"Nat. Commun."},{"key":"1464_CR16","doi-asserted-by":"publisher","first-page":"eaau5907","DOI":"10.1126\/scitranslmed.aau5907","volume":"11","author":"K Mestermann","year":"2019","unstructured":"Mestermann, K. et al. The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on\/off switch for CAR T cells. Sci. Transl. Med. 11, eaau5907 (2019).","journal-title":"Sci. Transl. Med."},{"key":"1464_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.immuni.2016.12.011","volume":"46","author":"D Druzd","year":"2017","unstructured":"Druzd, D. et al. Lymphocyte circadian clocks control lymph node trafficking and adaptive immune responses. Immunity 46, 120\u2013132 (2017).","journal-title":"Immunity"},{"key":"1464_CR18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-022-05605-0","volume":"614","author":"C Wang","year":"2023","unstructured":"Wang, C. et al. Dendritic cells direct circadian anti-tumour immune responses. Nature 614, 136\u2013143 (2023).","journal-title":"Nature"},{"key":"1464_CR19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.immuni.2018.01.004","volume":"48","author":"A Shimba","year":"2018","unstructured":"Shimba, A. et al. Glucocorticoids drive diurnal oscillations in T cell distribution and responses by inducing interleukin-7 receptor and CXCR4. Immunity 48, 286\u2013298.e6 (2018).","journal-title":"Immunity"},{"key":"1464_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.immuni.2012.05.021","volume":"37","author":"C Scheiermann","year":"2012","unstructured":"Scheiermann, C. et al. Adrenergic nerves govern circadian leukocyte recruitment to tissues. Immunity 37, 290\u2013301 (2012).","journal-title":"Immunity"},{"key":"1464_CR21","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1128\/MCB.25.7.2795-2807.2005","volume":"25","author":"EJ Eide","year":"2005","unstructured":"Eide, E. J. et al. Control of mammalian circadian rhythm by CKIepsilon-regulated proteasome-mediated PER2 degradation. Mol. Cell. Biol. 25, 2795\u20132807 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"1464_CR22","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.cell.2013.01.055","volume":"152","author":"S-H Yoo","year":"2013","unstructured":"Yoo, S.-H. et al. Competing E3 ubiquitin ligases govern circadian periodicity by degradation of CRY in nucleus and cytoplasm. Cell 152, 1091\u20131105 (2013).","journal-title":"Cell"},{"key":"1464_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/0748730405277232","volume":"20","author":"F Guillaumond","year":"2005","unstructured":"Guillaumond, F., Dardente, H., Gigu\u00e8re, V. & Cermakian, N. Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J. Biol. Rhythms 20, 391\u2013403 (2005).","journal-title":"J. Biol. Rhythms"},{"key":"1464_CR24","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1210\/me.2005-0057","volume":"19","author":"L Yin","year":"2005","unstructured":"Yin, L. & Lazar, M. A. The orphan nuclear receptor Rev-erbalpha recruits the N-CoR\/histone deacetylase 3 corepressor to regulate the circadian Bmal1 gene. Mol. Endocrinol. 19, 1452\u20131459 (2005).","journal-title":"Mol. Endocrinol."},{"key":"1464_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cell.2008.07.002","volume":"134","author":"Y Nakahata","year":"2008","unstructured":"Nakahata, Y. et al. The NAD\u2009+\u2009-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 134, 329\u2013340 (2008).","journal-title":"Cell"},{"key":"1464_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4049\/jimmunol.2200516","volume":"210","author":"N Cermakian","year":"2023","unstructured":"Cermakian, N. & Labrecque, N. Regulation of cytotoxic CD8\u2009+\u2009T cells by the circadian clock. J. Immunol. 210, 12\u201318 (2023).","journal-title":"J. Immunol."},{"key":"1464_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02111-0","volume":"8","author":"CE Sutton","year":"2017","unstructured":"Sutton, C. E. et al. Loss of the molecular clock in myeloid cells exacerbates T cell-mediated CNS autoimmune disease. Nat. Commun. 8, 1923 (2017).","journal-title":"Nat. Commun."},{"key":"1464_CR28","doi-asserted-by":"publisher","first-page":"20077","DOI":"10.1073\/pnas.1905080116","volume":"116","author":"CC Nobis","year":"2019","unstructured":"Nobis, C. C. et al. The circadian clock of CD8 T cells modulates their early response to vaccination and the rhythmicity of related signaling pathways. Proc. Natl. Acad. Sci. USA 116, 20077\u201320086 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1464_CR29","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/imm.13448","volume":"165","author":"CM Capelle","year":"2022","unstructured":"Capelle, C. M. et al. Stress hormone signalling inhibits Th1 polarization in a CD4 T-cell-intrinsic manner via mTORC1 and the circadian gene PER1. Immunology 165, 428\u2013444 (2022).","journal-title":"Immunology"},{"key":"1464_CR30","doi-asserted-by":"publisher","first-page":"6291","DOI":"10.4049\/jimmunol.1004030","volume":"187","author":"EE Fortier","year":"2011","unstructured":"Fortier, E. E. et al. Circadian variation of the response of T cells to antigen. J. Immunol. 187, 6291\u20136300 (2011).","journal-title":"J. Immunol."},{"key":"1464_CR31","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","volume":"45","author":"NE Scharping","year":"2016","unstructured":"Scharping, N. E. et al. The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity 45, 374\u2013388 (2016).","journal-title":"Immunity"},{"key":"1464_CR32","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1016\/j.cell.2024.04.015","volume":"187","author":"C Wang","year":"2024","unstructured":"Wang, C. et al. Circadian tumor infiltration and function of CD8\u2009+\u2009T cells dictate immunotherapy efficacy. Cell 187, 2690\u20132702.e17 (2024).","journal-title":"Cell"},{"key":"1464_CR33","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1158\/1541-7786.MCR-21-0786","volume":"20","author":"A Tsuruta","year":"2022","unstructured":"Tsuruta, A. et al. Diurnal expression of PD-1 on tumor-associated macrophages underlies the dosing time-dependent antitumor effects of the PD-1\/PD-L1 inhibitor BMS-1 in B16\/BL6 MELANOMA-BEARING Mice. Mol. Cancer Res. 20, 972\u2013982 (2022).","journal-title":"Mol. Cancer Res."},{"key":"1464_CR34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry, E. J. T cell exhaustion. Nat. Immunol. 12, 492\u2013499 (2011).","journal-title":"Nat. Immunol."},{"key":"1464_CR35","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","volume":"37","author":"LM McLane","year":"2019","unstructured":"McLane, L. M., Abdel-Hakeem, M. S. & Wherry, E. J. CD8 T cell exhaustion during chronic viral infection and cancer. Annu. Rev. Immunol. 37, 457\u2013495 (2019).","journal-title":"Annu. Rev. Immunol."},{"key":"1464_CR36","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","volume":"19","author":"CU Blank","year":"2019","unstructured":"Blank, C. U. et al. Defining \u201cT cell exhaustion\u201d. Nat. Rev. Immunol. 19, 665\u2013674 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"1464_CR37","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41570-025-00768-6","volume":"9","author":"EL Adams","year":"2025","unstructured":"Adams, E. L. et al. Small-molecule control of CAR T cells. Nat. Rev. Chem. 9, 809\u2013825 (2025).","journal-title":"Nat. Rev. Chem."},{"key":"1464_CR38","doi-asserted-by":"publisher","first-page":"e124430","DOI":"10.1172\/jci.insight.124430","volume":"5","author":"-H Leung","year":"2019","unstructured":"Leung, -H. et al. Sensitive and adaptable pharmacological control of CAR T cells through extracellular receptor dimerization. JCI Insight 5, e124430 (2019).","journal-title":"JCI Insight"},{"key":"1464_CR39","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nature06685","volume":"452","author":"S M\u00e9ndez-Ferrer","year":"2008","unstructured":"M\u00e9ndez-Ferrer, S., Lucas, D., Battista, M. & Frenette, P. S. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 452, 442\u2013447 (2008).","journal-title":"Nature"},{"key":"1464_CR40","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/s41590-024-01859-0","volume":"25","author":"BM Fortin","year":"2024","unstructured":"Fortin, B. M. et al. Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade. Nat. Immunol. 25, 1257\u20131269 (2024).","journal-title":"Nat. Immunol."},{"key":"1464_CR41","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s12276-021-00681-0","volume":"53","author":"Y Lee","year":"2021","unstructured":"Lee, Y. Roles of circadian clocks in cancer pathogenesis and treatment. Exp. Mol. Med. 53, 1529\u20131538 (2021).","journal-title":"Exp. Mol. Med."},{"key":"1464_CR42","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.bbagen.2014.10.025","volume":"1850","author":"LD Jensen","year":"2015","unstructured":"Jensen, L. D. The circadian clock and hypoxia in tumor cell de-differentiation and metastasis. Biochim. Biophys. Acta 1850, 1633\u20131641 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"1464_CR43","doi-asserted-by":"publisher","first-page":"e008011","DOI":"10.1136\/jitc-2023-008011","volume":"12","author":"JS Patel","year":"2024","unstructured":"Patel, J. S. et al. Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis. J. Immunother. Cancer 12, e008011 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"1464_CR44","doi-asserted-by":"publisher","first-page":"115748","DOI":"10.1016\/j.ejca.2025.115748","volume":"228","author":"A Tsukaguchi","year":"2025","unstructured":"Tsukaguchi, A. et al. Timing of first pembrolizumab infusion and long-term outcomes in non-small cell lung cancer: a retrospective multicenter study. Eur. J. Cancer 228, 115748 (2025).","journal-title":"Eur. J. Cancer"},{"key":"1464_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13045-025-01744-9","volume":"18","author":"M-C Vo","year":"2025","unstructured":"Vo, M.-C. et al. Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: Why are approvals restricted to hematologic malignancies? J. Hematol. Oncol. 18, 91 (2025).","journal-title":"J. Hematol. Oncol."},{"key":"1464_CR46","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.trecan.2025.08.014","volume":"11","author":"KP Mueller","year":"2025","unstructured":"Mueller, K. P., Grenier, J. M. & Weber, E. W. CAR T cell persistence in cancer. Trends Cancer 11, 1005\u20131018 (2025).","journal-title":"Trends Cancer"},{"key":"1464_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02386-8","volume":"24","author":"SS Azeez","year":"2025","unstructured":"Azeez, S. S. et al. Advancing CAR-based cell therapies for solid tumours: challenges, therapeutic strategies, and perspectives. Mol. Cancer 24, 191 (2025).","journal-title":"Mol. Cancer"},{"key":"1464_CR48","doi-asserted-by":"crossref","unstructured":"Bimbo, J. F. et al. T cell-specific non-viral DNA delivery and in vivo CAR-T generation using targeted lipid nanoparticles. J. Immunother. Cancer 13, (2025).","DOI":"10.1136\/jitc-2025-011759"},{"key":"1464_CR49","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1182\/blood.2024024523","volume":"144","author":"CJ Nicolai","year":"2024","unstructured":"Nicolai, C. J. et al. In vivo CAR T-cell generation in nonhuman primates using lentiviral vectors displaying a multidomain fusion ligand. Blood 144, 977\u2013987 (2024).","journal-title":"Blood"},{"key":"1464_CR50","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev-bioeng-070620-033348","volume":"23","author":"NN Parayath","year":"2021","unstructured":"Parayath, N. N. & Stephan, M. T. In situ programming of CAR T cells. Annu. Rev. Biomed. Eng. 23, 385\u2013405 (2021).","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"1464_CR51","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/s41587-023-02085-z","volume":"42","author":"JR Hamilton","year":"2024","unstructured":"Hamilton, J. R. et al. In vivo human T cell engineering with enveloped delivery vehicles. Nat. Biotechnol. 42, 1684\u20131692 (2024).","journal-title":"Nat. Biotechnol."},{"key":"1464_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00508-1","volume":"11","author":"W Nawaz","year":"2021","unstructured":"Nawaz, W. et al. AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia. Blood Cancer J. 11, 119 (2021).","journal-title":"Blood Cancer J."},{"key":"1464_CR53","doi-asserted-by":"publisher","first-page":"eaba1786","DOI":"10.1126\/science.aba1786","volume":"372","author":"EW Weber","year":"2021","unstructured":"Weber, E. W. et al. Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling. Science 372, eaba1786 (2021).","journal-title":"Science"},{"key":"1464_CR54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41577-021-00547-6","volume":"22","author":"EC Morris","year":"2022","unstructured":"Morris, E. C., Neelapu, S. S., Giavridis, T. & Sadelain, M. Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy. Nat. Rev. Immunol. 22, 85\u201396 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1464_CR55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/07420528909059144","volume":"6","author":"AJ Lewy","year":"1989","unstructured":"Lewy, A. J. & Sack, R. L. The dim light melatonin onset as a marker for circadian phase position. Chronobiol. Int. 6, 93\u2013102 (1989).","journal-title":"Chronobiol. Int."},{"key":"1464_CR56","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1016\/j.lfs.2003.05.007","volume":"73","author":"B Selmaoui","year":"2003","unstructured":"Selmaoui, B. & Touitou, Y. Reproducibility of the circadian rhythms of serum cortisol and melatonin in healthy subjects: a study of three different 24-h cycles over six weeks. Life Sci. 73, 3339\u20133349 (2003).","journal-title":"Life Sci."},{"key":"1464_CR57","doi-asserted-by":"publisher","first-page":"1606242","DOI":"10.3389\/fendo.2025.1606242","volume":"16","author":"J Bautista","year":"2025","unstructured":"Bautista, J., Ojeda-Mosquera, S., Ord\u00f3\u00f1ez-Lozada, D. & L\u00f3pez-Cort\u00e9s, A. Peripheral clocks and systemic zeitgeber interactions: from molecular mechanisms to circadian precision medicine. Front. Endocrinol. 16, 1606242 (2025).","journal-title":"Front. Endocrinol."},{"key":"1464_CR58","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1245\/s10434-025-18315-4","volume":"33","author":"F Zhang","year":"2026","unstructured":"Zhang, F., Chen, M., Hu, S., Pang, K. & Jin, W. Circadian rhythms in cancer: mechanistic insights, chronotherapeutic strategies, and translational challenges. Ann. Surg. Oncol. 33, 296\u2013308 (2026).","journal-title":"Ann. Surg. Oncol."},{"key":"1464_CR59","doi-asserted-by":"publisher","first-page":"1141880","DOI":"10.3389\/fmed.2023.1141880","volume":"10","author":"R Wakao","year":"2023","unstructured":"Wakao, R. & Fukaya-Shiba, A. In vivo CAR T cells and targeted gene delivery: a theme for the Pharmaceuticals and Medical Devices Agency Science Board to address. Front. Med. 10, 1141880 (2023).","journal-title":"Front. Med."},{"key":"1464_CR60","doi-asserted-by":"publisher","first-page":"eabb0738","DOI":"10.1126\/science.abb0738","volume":"371","author":"A Sancar","year":"2021","unstructured":"Sancar, A. & Van Gelder, R. N. Clocks, cancer, and chronochemotherapy. Science 371, eabb0738 (2021).","journal-title":"Science"},{"key":"1464_CR61","doi-asserted-by":"publisher","unstructured":"Luan, D. et al. Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma. Blood.https:\/\/doi.org\/10.1182\/blood.2025031476 (2025).","DOI":"10.1182\/blood.2025031476"},{"key":"1464_CR62","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41420-024-01960-1","volume":"10","author":"Y Zeng","year":"2024","unstructured":"Zeng, Y., Guo, Z., Wu, M., Chen, F. & Chen, L. Circadian rhythm regulates the function of immune cells and participates in the development of tumors. Cell Death Discov. 10, 199 (2024).","journal-title":"Cell Death Discov."},{"key":"1464_CR63","doi-asserted-by":"publisher","first-page":"7864229","DOI":"10.1155\/jimr\/7864229","volume":"2026","author":"J Bautista","year":"2026","unstructured":"Bautista, J. et al. Next-generation immune checkpoints and tumor microenvironment modulation in cancer immunotherapy. J. Immunol. Res. 2026, 7864229 (2026).","journal-title":"J. Immunol. Res."},{"key":"1464_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2468-2","volume":"11","author":"A Parascandolo","year":"2020","unstructured":"Parascandolo, A. et al. Effect of naive and cancer-educated fibroblasts on colon cancer cell circadian growth rhythm. Cell Death Dis. 11, 289 (2020).","journal-title":"Cell Death Dis."},{"key":"1464_CR65","first-page":"100659","volume":"5","author":"T Hirata","year":"2024","unstructured":"Hirata, T. et al. Brief report: clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with locally advanced NSCLC. JTO Clin. Res. Rep. 5, 100659 (2024).","journal-title":"JTO Clin. Res. Rep."},{"key":"1464_CR66","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41416-024-02704-9","volume":"131","author":"A Karabou\u00e9","year":"2024","unstructured":"Karabou\u00e9, A. et al. Why does circadian timing of administration matter for immune checkpoint inhibitors\u2019 efficacy? Br. J. Cancer 131, 783\u2013796 (2024).","journal-title":"Br. J. Cancer"},{"key":"1464_CR67","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.1038\/s44319-024-00288-2","volume":"25","author":"AM Knudsen-Clark","year":"2024","unstructured":"Knudsen-Clark, A. M. et al. Circadian rhythms of macrophages are altered by the acidic tumor microenvironment. EMBO Rep. 25, 5080\u20135112 (2024).","journal-title":"EMBO Rep."},{"key":"1464_CR68","doi-asserted-by":"publisher","first-page":"1617198","DOI":"10.3389\/fcimb.2025.1617198","volume":"15","author":"J Bautista","year":"2025","unstructured":"Bautista, J. & Lopez-Cortes, A. Oncogenic viruses rewire the epigenome in human cancer. Front. Cell. Infect. Microbiol. 15, 1617198 (2025).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1464_CR69","doi-asserted-by":"publisher","first-page":"113959","DOI":"10.1016\/j.jconrel.2025.113959","volume":"385","author":"A Cimino","year":"2025","unstructured":"Cimino, A. et al. Programmable chronogenetic gene circuits for self-regulated circadian delivery of biologic drugs. J. Control. Release 385, 113959 (2025).","journal-title":"J. Control. Release"},{"key":"1464_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13036-025-00519-7","volume":"19","author":"A Cimino","year":"2025","unstructured":"Cimino, A. et al. Dual-responsive synthetic gene circuit for dynamic biologic drug delivery via inflammatory and circadian signaling pathways. J. Biol. Eng. 19, 47 (2025).","journal-title":"J. Biol. Eng."},{"key":"1464_CR71","doi-asserted-by":"publisher","first-page":"1493346","DOI":"10.3389\/fphar.2025.1493346","volume":"16","author":"W He","year":"2025","unstructured":"He, W. et al. TCR-T cell therapy for solid tumors: challenges and emerging solutions. Front. Pharmacol. 16, 1493346 (2025).","journal-title":"Front. Pharmacol."},{"key":"1464_CR72","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.tips.2024.03.004","volume":"45","author":"L Short","year":"2024","unstructured":"Short, L., Holt, R. A., Cullis, P. R. & Evgin, L. Direct in vivo CAR T cell engineering. Trends Pharmacol. Sci. 45, 406\u2013418 (2024).","journal-title":"Trends Pharmacol. Sci."},{"key":"1464_CR73","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1016\/j.ymthe.2024.08.002","volume":"32","author":"MB Demircan","year":"2024","unstructured":"Demircan, M. B. et al. T-cell specific in vivo gene delivery with DART-AAVs targeted to CD8. Mol. Ther. 32, 3470\u20133484 (2024).","journal-title":"Mol. Ther."},{"key":"1464_CR74","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.omtm.2021.09.014","volume":"23","author":"A Michels","year":"2021","unstructured":"Michels, A. et al. Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8. Mol. Ther. gs Clin. Dev. 23, 334\u2013347 (2021).","journal-title":"Mol. Ther. gs Clin. Dev."},{"key":"1464_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-06052-3","volume":"23","author":"E Pinto","year":"2025","unstructured":"Pinto, E. et al. From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy. J. Transl. Med. 23, 10 (2025).","journal-title":"J. Transl. Med."},{"key":"1464_CR76","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1016\/j.ymthe.2025.06.036","volume":"33","author":"JI Andorko","year":"2025","unstructured":"Andorko, J. I. et al. Targeted in vivo delivery of genetic medicines utilizing an engineered lentiviral vector platform results in CAR T and NK cell generation. Mol. Ther. 33, 4937\u20134952 (2025).","journal-title":"Mol. Ther."},{"key":"1464_CR77","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1016\/j.ymthe.2025.07.006","volume":"33","author":"T Coradin","year":"2025","unstructured":"Coradin, T. et al. Efficient in vivo generation of CAR T cells using a retargeted fourth-generation lentiviral vector. Mol. Ther. 33, 4953\u20134967 (2025).","journal-title":"Mol. Ther."},{"key":"1464_CR78","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41577-025-01174-1","volume":"25","author":"Y-R Li","year":"2025","unstructured":"Li, Y.-R., Zhu, Y., Halladay, T. & Yang, L. In vivo CAR engineering for immunotherapy. Nat. Rev. Immunol. 25, 725\u2013744 (2025).","journal-title":"Nat. Rev. Immunol."},{"key":"1464_CR79","doi-asserted-by":"publisher","first-page":"e006292","DOI":"10.1136\/jitc-2022-006292","volume":"11","author":"KR Michels","year":"2023","unstructured":"Michels, K. R. et al. Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering. J. Immunother. Cancer 11, e006292 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"1464_CR80","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"1464_CR81","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1039\/D4QM00479E","volume":"8","author":"Y Qu","year":"2024","unstructured":"Qu, Y., Liu, R., Sun, D. & Dai, Z. Critical considerations of mRNA\u2013LNP technology for CAR-T therapy: components, payloads and emerging horizons. Mater. Chem. Front. 8, 3106\u20133135 (2024).","journal-title":"Mater. Chem. Front."},{"key":"1464_CR82","doi-asserted-by":"publisher","first-page":"e2109256118","DOI":"10.1073\/pnas.2109256118","volume":"118","author":"SA Dilliard","year":"2021","unstructured":"Dilliard, S. A., Cheng, Q. & Siegwart, D. J. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc Natl Acad Sci USA 118, e2109256118 (2021).","journal-title":"Proc Natl Acad Sci USA"},{"key":"1464_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50093-7","volume":"15","author":"K Su","year":"2024","unstructured":"Su, K. et al. Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation. Nat. Commun. 15, 5659 (2024).","journal-title":"Nat. Commun."},{"key":"1464_CR84","doi-asserted-by":"publisher","first-page":"e2304378","DOI":"10.1002\/smll.202304378","volume":"20","author":"MM Billingsley","year":"2024","unstructured":"Billingsley, M. M. et al. In vivo mRNA CAR T cell engineering via targeted ionizable lipid nanoparticles with extrahepatic tropism. Small 20, e2304378 (2024).","journal-title":"Small"},{"key":"1464_CR85","doi-asserted-by":"publisher","unstructured":"Chen, M. Z. et al. A versatile antibody capture system drives specific in vivo delivery of mRNA-loaded lipid nanoparticles. Nat. Nanotechnol. https:\/\/doi.org\/10.1038\/s41565-025-01954-9 (2025).","DOI":"10.1038\/s41565-025-01954-9"},{"key":"1464_CR86","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1007\/s13346-024-01585-y","volume":"14","author":"JR Maga\u00f1a Rodriguez","year":"2024","unstructured":"Maga\u00f1a Rodriguez, J. R., Guerra-Rebollo, M., Borr\u00f3s, S. & Fornaguera, C. Nucleic acid-loaded poly(beta-aminoester) nanoparticles for cancer nano-immuno therapeutics: the good, the bad, and the future. Drug Deliv. Transl. Res. 14, 3477\u20133493 (2024).","journal-title":"Drug Deliv. Transl. Res."},{"key":"1464_CR87","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41573-021-00189-2","volume":"20","author":"AJ Hou","year":"2021","unstructured":"Hou, A. J., Chen, L. C. & Chen, Y. Y. Navigating CAR-T cells through the solid-tumour microenvironment. Nat. Rev. Drug Discov. 20, 531\u2013550 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1464_CR88","doi-asserted-by":"publisher","first-page":"1652047","DOI":"10.3389\/fcell.2025.1652047","volume":"13","author":"NC Kyriakidis","year":"2025","unstructured":"Kyriakidis, N. C. et al. Reprogramming cancer immunity with next-generation combination therapies. Front. Cell Dev. Biol. 13, 1652047 (2025).","journal-title":"Front. Cell Dev. Biol."},{"key":"1464_CR89","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s43046-025-00262-6","volume":"37","author":"SS Jangavali","year":"2025","unstructured":"Jangavali, S. S. et al. From lab to lifesaver: the rise of CAR T-cell therapy in oncology. J. Egypt Natl. Canc Inst. 37, 37 (2025).","journal-title":"J. Egypt Natl. Canc Inst."},{"key":"1464_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04292-3","volume":"21","author":"G Dagar","year":"2023","unstructured":"Dagar, G. et al. Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments. J. Transl. Med. 21, 449 (2023).","journal-title":"J. Transl. Med."},{"key":"1464_CR91","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1158\/1078-0432.CCR-22-1491","volume":"29","author":"JD Clubb","year":"2023","unstructured":"Clubb, J. D., Gao, T. A. & Chen, Y. Y. Synthetic Biology in the Engineering of CAR-T and CAR-NK Cell Therapies: Facts and Hopes. Clin. Cancer Res. 29, 1390\u20131402 (2023).","journal-title":"Clin. Cancer Res."},{"key":"1464_CR92","doi-asserted-by":"publisher","first-page":"100506","DOI":"10.1016\/j.coisb.2024.100506","volume":"37","author":"J Hesse","year":"2024","unstructured":"Hesse, J., Nelson, N. & Rel\u00f3gio, A. Shaping the future of precision oncology: Integrating circadian medicine and mathematical models for personalized cancer treatment. Curr. Opin. Syst. Biol. 37, 100506 (2024).","journal-title":"Curr. Opin. Syst. Biol."},{"key":"1464_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05957-3","volume":"22","author":"W Xu","year":"2024","unstructured":"Xu, W., Zhang, S., Qin, H. & Yao, K. From bench to bedside: cutting-edge applications of base editing and prime editing in precision medicine. J. Transl. Med. 22, 1133 (2024).","journal-title":"J. Transl. Med."},{"key":"1464_CR94","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1016\/j.ymthe.2025.03.026","volume":"33","author":"D Liu","year":"2025","unstructured":"Liu, D., Cao, D. & Han, R. Recent advances in therapeutic gene-editing technologies. Mol. Ther. 33, 2619\u20132644 (2025).","journal-title":"Mol. Ther."},{"key":"1464_CR95","doi-asserted-by":"publisher","first-page":"e2427216122","DOI":"10.1073\/pnas.2427216122","volume":"122","author":"NW Engel","year":"2025","unstructured":"Engel, N. W. et al. Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR\/Cas9 nuclease-engineered T cells. Proc. Natl. Acad. Sci. USA 122, e2427216122 (2025).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1464_CR96","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa2300709","volume":"389","author":"R Chiesa","year":"2023","unstructured":"Chiesa, R. et al. Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia. N. Engl. J. Med. 389, 899\u2013910 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1464_CR97","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1038\/s41375-021-01282-6","volume":"35","author":"C Georgiadis","year":"2021","unstructured":"Georgiadis, C. et al. Base-edited CAR T cells for combinational therapy against T cell malignancies. Leukemia 35, 3466\u20133481 (2021).","journal-title":"Leukemia"},{"key":"1464_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64761-9","volume":"16","author":"N Franko","year":"2025","unstructured":"Franko, N. et al. Regulation of therapeutic protein release in response to circadian biomarkers. Nat. Commun. 16, 9812 (2025).","journal-title":"Nat. Commun."},{"key":"1464_CR99","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1038\/s41417-024-00823-2","volume":"31","author":"W Xiao","year":"2024","unstructured":"Xiao, W. et al. FGFR4-specific CAR-T cells with inducible caspase-9 suicide gene as an approach to treat rhabdomyosarcoma. Cancer Gene Ther. 31, 1571\u20131584 (2024).","journal-title":"Cancer Gene Ther."},{"key":"1464_CR100","doi-asserted-by":"publisher","first-page":"eadj6251","DOI":"10.1126\/sciadv.adj6251","volume":"10","author":"L Lu","year":"2024","unstructured":"Lu, L., Xie, M., Yang, B., Zhao, W.-B. & Cao, J. Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control. Sci. Adv. 10, eadj6251 (2024).","journal-title":"Sci. Adv."},{"key":"1464_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-020-00238-9","volume":"8","author":"Q Liao","year":"2020","unstructured":"Liao, Q. et al. Engineering T cells with hypoxia-inducible chimeric antigen receptor (HiCAR) for selective tumor killing. Biomark. Res. 8, 56 (2020).","journal-title":"Biomark. Res."},{"key":"1464_CR102","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41586-022-04875-y","volume":"607","author":"Z Diamantopoulou","year":"2022","unstructured":"Diamantopoulou, Z. et al. The metastatic spread of breast cancer accelerates during sleep. Nature 607, 156\u2013162 (2022).","journal-title":"Nature"},{"key":"1464_CR103","doi-asserted-by":"publisher","first-page":"1677481","DOI":"10.3389\/fcell.2025.1677481","volume":"13","author":"J Bautista","year":"2025","unstructured":"Bautista, J. & L\u00f3pez-Cort\u00e9s, A. Deciphering organotropism reveals therapeutic targets in metastasis. Front. Cell Dev. Biol 13, 1677481 (2025).","journal-title":"Front. Cell Dev. Biol"},{"key":"1464_CR104","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.trecan.2025.06.011","volume":"11","author":"CA Tellinga","year":"2025","unstructured":"Tellinga, C. A., Friedli, R., Simonetta, F. & Scheiermann, C. Time-of-day dependency of adoptive cell therapies. Trends Cancer 11, 927\u2013933 (2025).","journal-title":"Trends Cancer"},{"key":"1464_CR105","doi-asserted-by":"publisher","first-page":"113550","DOI":"10.1016\/j.isci.2025.113550","volume":"28","author":"J Bautista","year":"2025","unstructured":"Bautista, J. et al. Neurodegeneration rewires the tumor microenvironment via the neuro-immune-cancer axis. iScience 28, 113550 (2025).","journal-title":"iScience"},{"key":"1464_CR106","doi-asserted-by":"publisher","unstructured":"Lamplugh, Z. L., Wellhausen, N., June, C. H. & Fan, Y. Microenvironmental regulation of solid tumour resistance to CAR T cell therapy. Nat. Rev. Immunol. https:\/\/doi.org\/10.1038\/s41577-025-01229-3 (2025)","DOI":"10.1038\/s41577-025-01229-3"},{"key":"1464_CR107","doi-asserted-by":"publisher","first-page":"645","DOI":"10.14336\/AD.2024.0327","volume":"16","author":"D Li","year":"2024","unstructured":"Li, D. et al. Chronobiology of the Tumor Microenvironment: Implications for Therapeutic Strategies and Circadian-Based Interventions. Aging Dis. 16, 645\u2013657 (2024).","journal-title":"Aging Dis."},{"key":"1464_CR108","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cmet.2016.09.010","volume":"25","author":"CB Peek","year":"2017","unstructured":"Peek, C. B. et al. Circadian clock interaction with HIF1\u03b1 mediates oxygenic metabolism and anaerobic glycolysis in skeletal muscle. Cell Metab. 25, 86\u201392 (2017).","journal-title":"Cell Metab."},{"key":"1464_CR109","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.1038\/s44318-024-00235-w","volume":"43","author":"R Vuillefroy de Silly","year":"2024","unstructured":"Vuillefroy de Silly, R., Pericou, L., Seijo, B., Crespo, I. & Irving, M. Acidity suppresses CD8\u2009+\u2009T-cell function by perturbing IL-2, mTORC1, and c-Myc signaling. EMBO J. 43, 4922\u20134953 (2024).","journal-title":"EMBO J."},{"key":"1464_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-15246-y","volume":"12","author":"A L\u00f3pez-Cort\u00e9s","year":"2022","unstructured":"L\u00f3pez-Cort\u00e9s, A. et al. The close interaction between hypoxia-related proteins and metastasis in pancarcinomas. Sci. Rep. 12, 11100 (2022).","journal-title":"Sci. Rep."},{"key":"1464_CR111","doi-asserted-by":"publisher","first-page":"e70504","DOI":"10.1002\/jmv.70504","volume":"97","author":"J Bautista","year":"2025","unstructured":"Bautista, J., \u00c1vila-Coello, D., Hidalgo-Tinoco, C., Bueno-Mi\u00f1o, J. & L\u00f3pez-Cort\u00e9s, A. Unraveling the gut-brain-immune interplay in herpes simplex virus-associated neurodegeneration. J. Med. Virol. 97, e70504 (2025).","journal-title":"J. Med. Virol."},{"key":"1464_CR112","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1016\/j.vaccine.2016.04.032","volume":"34","author":"JE Long","year":"2016","unstructured":"Long, J. E. et al. Morning vaccination enhances antibody response over afternoon vaccination: a cluster-randomised trial. Vaccine 34, 2679\u20132685 (2016).","journal-title":"Vaccine"},{"key":"1464_CR113","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1073\/pnas.1106750109","volume":"109","author":"JE Gibbs","year":"2012","unstructured":"Gibbs, J. E. et al. The nuclear receptor REV-ERB\u03b1 mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines. Proc. Natl. Acad. Sci. USA 109, 582\u2013587 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1464_CR114","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s41409-023-02016-1","volume":"58","author":"K Baur","year":"2023","unstructured":"Baur, K. et al. CD4\u2009+\u2009CAR T-cell expansion is associated with response and therapy related toxicities in patients with B-cell lymphomas. Bone Marrow Transpl. 58, 1048\u20131050 (2023).","journal-title":"Bone Marrow Transpl."},{"key":"1464_CR115","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1084\/jem.20050732","volume":"202","author":"L Gattinoni","year":"2005","unstructured":"Gattinoni, L. et al. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8\u2009+\u2009T cells. J. Exp. Med. 202, 907\u2013912 (2005).","journal-title":"J. Exp. Med."},{"key":"1464_CR116","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature12626","volume":"501","author":"MR Junttila","year":"2013","unstructured":"Junttila, M. R. & de Sauvage, F. J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501, 346\u2013354 (2013).","journal-title":"Nature"},{"key":"1464_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07454-x","volume":"16","author":"Z Wang","year":"2025","unstructured":"Wang, Z. et al. CAR-T therapy dilemma and innovative design strategies for next generation. Cell Death Dis. 16, 211 (2025).","journal-title":"Cell Death Dis."},{"key":"1464_CR118","doi-asserted-by":"publisher","unstructured":"Dowling, M. R. et al. Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma. Blood. https:\/\/doi.org\/10.1182\/blood.2025032307 (2026).","DOI":"10.1182\/blood.2025032307"},{"key":"1464_CR119","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","volume":"375","author":"JG Rurik","year":"2022","unstructured":"Rurik, J. G. et al. CAR T cells produced in vivo to treat cardiac injury. Science 375, 91\u201396 (2022).","journal-title":"Science"},{"key":"1464_CR120","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nnano.2017.57","volume":"12","author":"TT Smith","year":"2017","unstructured":"Smith, T. T. et al. In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers. Nat. Nanotechnol. 12, 813\u2013820 (2017).","journal-title":"Nat. Nanotechnol."},{"key":"1464_CR121","doi-asserted-by":"publisher","first-page":"aab4077","DOI":"10.1126\/science.aab4077","volume":"350","author":"C-Y Wu","year":"2015","unstructured":"Wu, C.-Y., Roybal, K. T., Puchner, E. M., Onuffer, J. & Lim, W. A. Remote control of therapeutic T cells through a small molecule-gated chimeric receptor. Science 350, aab4077 (2015).","journal-title":"Science"},{"key":"1464_CR122","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3390\/cancers14040896","volume":"14","author":"A Karabou\u00e9","year":"2022","unstructured":"Karabou\u00e9, A. et al. Time-Dependent efficacy of checkpoint inhibitor nivolumab: results from a pilot study in patients with metastatic non-small-cell lung cancer. Cancers 14, 896 (2022).","journal-title":"Cancers"},{"key":"1464_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/srep41220","volume":"7","author":"JC Borniger","year":"2017","unstructured":"Borniger, J. C. et al. Time-of-day dictates transcriptional inflammatory responses to cytotoxic chemotherapy. Sci. Rep. 7, 41220 (2017).","journal-title":"Sci. Rep."},{"key":"1464_CR124","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1172\/JCI120874","volume":"128","author":"N Wittenbrink","year":"2018","unstructured":"Wittenbrink, N. et al. High-accuracy determination of internal circadian time from a single blood sample. J. Clin. Invest. 128, 3826\u20133839 (2018).","journal-title":"J. Clin. Invest."},{"key":"1464_CR125","first-page":"303","volume":"183","author":"AJ Lewy","year":"1995","unstructured":"Lewy, A. J. et al. Melatonin marks circadian phase position and resets the endogenous circadian pacemaker in humans. Ciba Found. Symp. 183, 303\u2013317 (1995).","journal-title":"Ciba Found. Symp."},{"key":"1464_CR126","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1182\/blood-2003-03-0779","volume":"102","author":"DB Boivin","year":"2003","unstructured":"Boivin, D. B. et al. Circadian clock genes oscillate in human peripheral blood mononuclear cells. Blood 102, 4143\u20134145 (2003).","journal-title":"Blood"},{"key":"1464_CR127","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/0748730412475041","volume":"28","author":"M Juda","year":"2013","unstructured":"Juda, M., Vetter, C. & Roenneberg, T. The Munich chronotype questionnaire for shift-workers (MCTQShift). J. Biol. Rhythms 28, 130\u2013140 (2013).","journal-title":"J. Biol. Rhythms"},{"key":"1464_CR128","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/sleep\/26.3.342","volume":"26","author":"S Ancoli-Israel","year":"2003","unstructured":"Ancoli-Israel, S. et al. The role of actigraphy in the study of sleep and circadian rhythms. Sleep 26, 342\u2013392 (2003).","journal-title":"Sleep"},{"key":"1464_CR129","first-page":"97","volume":"4","author":"JA Horne","year":"1976","unstructured":"Horne, J. A. & Ostberg, O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int. J. Chronobiol. 4, 97\u2013110 (1976).","journal-title":"Int. J. Chronobiol."},{"key":"1464_CR130","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2217\/imt-2022-0139","volume":"15","author":"C Yeung","year":"2023","unstructured":"Yeung, C., Kartolo, A., Tong, J., Hopman, W. & Baetz, T. Association of circadian timing of initial infusions of immune checkpoint inhibitors with survival in advanced melanoma. Immunotherapy 15, 819\u2013826 (2023).","journal-title":"Immunotherapy"},{"key":"1464_CR131","doi-asserted-by":"publisher","first-page":"105607","DOI":"10.1016\/j.ebiom.2025.105607","volume":"113","author":"Z Huang","year":"2025","unstructured":"Huang, Z. et al. Overall survival according to time-of-day of combined immuno-chemotherapy for advanced non-small cell lung cancer: a bicentric bicontinental study. EBioMedicine 113, 105607 (2025).","journal-title":"EBioMedicine"},{"key":"1464_CR132","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"A-W Chan","year":"2013","unstructured":"Chan, A.-W. et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann. Intern. Med. 158, 200\u2013207 (2013).","journal-title":"Ann. Intern. Med."},{"key":"1464_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-18","volume":"8","author":"KF Schulz","year":"2010","unstructured":"Schulz, K. F., Altman, D. G. & Moher, D. & CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med 8, 18 (2010).","journal-title":"BMC Med"},{"key":"1464_CR134","doi-asserted-by":"publisher","first-page":"zsaa180","DOI":"10.1093\/sleep\/zsaa180","volume":"44","author":"P Cheng","year":"2021","unstructured":"Cheng, P. et al. Predicting circadian misalignment with wearable technology: validation of wrist-worn actigraphy and photometry in night shift workers. Sleep 44, zsaa180 (2021).","journal-title":"Sleep"},{"key":"1464_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16429-8","volume":"7","author":"M Cuesta","year":"2017","unstructured":"Cuesta, M., Boudreau, P., Cermakian, N. & Boivin, D. B. Rapid resetting of human peripheral clocks by phototherapy during simulated night shift work. Sci. Rep. 7, 16310 (2017).","journal-title":"Sci. Rep."},{"key":"1464_CR136","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.4049\/jimmunol.1502422","volume":"196","author":"M Cuesta","year":"2016","unstructured":"Cuesta, M., Boudreau, P., Dubeau-Laram\u00e9e, G., Cermakian, N. & Boivin, D. B. Simulated night shift disrupts circadian rhythms of immune functions in humans. J. Immunol. 196, 2466\u20132475 (2016).","journal-title":"J. Immunol."},{"key":"1464_CR137","doi-asserted-by":"publisher","first-page":"5796","DOI":"10.4049\/jimmunol.1001026","volume":"185","author":"O Castanon-Cervantes","year":"2010","unstructured":"Castanon-Cervantes, O. et al. Dysregulation of inflammatory responses by chronic circadian disruption. J. Immunol. 185, 5796\u20135805 (2010).","journal-title":"J. Immunol."},{"key":"1464_CR138","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/j.cub.2017.04.059","volume":"27","author":"SMT Wehrens","year":"2017","unstructured":"Wehrens, S. M. T. et al. Meal timing regulates the human circadian system. Curr. Biol. 27, 1768\u20131775.e3 (2017).","journal-title":"Curr. Biol."},{"key":"1464_CR139","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1126\/science.aaa4967","volume":"348","author":"SA Rosenberg","year":"2015","unstructured":"Rosenberg, S. A. & Restifo, N. P. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348, 62\u201368 (2015).","journal-title":"Science"},{"key":"1464_CR140","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1182\/blood.2024024166","volume":"143","author":"M Elsallab","year":"2024","unstructured":"Elsallab, M. et al. Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System. Blood 143, 2099\u20132105 (2024).","journal-title":"Blood"},{"key":"1464_CR141","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.ccell.2025.03.019","volume":"43","author":"B Du","year":"2025","unstructured":"Du, B. et al. CAR-T therapy in solid tumors. Cancer Cell 43, 665\u2013679 (2025).","journal-title":"Cancer Cell"},{"key":"1464_CR142","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.3390\/ijms23063154","volume":"23","author":"X Si","year":"2022","unstructured":"Si, X., Xiao, L., Brown, C. E. & Wang, D. Preclinical evaluation of CAR T cell function: in vitro and in vivo models. Int. J. Mol. Sci. 23, 3154 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1464_CR143","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6673-5-18","volume":"5","author":"A van Mark","year":"2010","unstructured":"van Mark, A. et al. The impact of shift work induced chronic circadian disruption on IL-6 and TNF-alpha immune responses. J. Occup. Med. Toxicol. 5, 18 (2010).","journal-title":"J. Occup. Med. Toxicol."},{"key":"1464_CR144","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41556-019-0441-z","volume":"22","author":"J Chang","year":"2020","unstructured":"Chang, J. et al. Circadian control of the secretory pathway maintains collagen homeostasis. Nat. Cell Biol. 22, 74\u201386 (2020).","journal-title":"Nat. Cell Biol."},{"key":"1464_CR145","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02040-9","volume":"23","author":"Y Jin","year":"2024","unstructured":"Jin, Y. et al. Advances in spatial transcriptomics and its applications in cancer research. Mol. Cancer 23, 129 (2024).","journal-title":"Mol. Cancer"},{"key":"1464_CR146","doi-asserted-by":"publisher","first-page":"809754","DOI":"10.3389\/fonc.2022.809754","volume":"12","author":"T Xin","year":"2022","unstructured":"Xin, T. et al. In-vivo induced CAR-T cell for the potential breakthrough to overcome the barriers of current CAR-T cell therapy. Front. Oncol. 12, 809754 (2022).","journal-title":"Front. Oncol."},{"key":"1464_CR147","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s42003-023-04978-w","volume":"6","author":"SP Fraessle","year":"2023","unstructured":"Fraessle, S. P. et al. Activation-inducible CAR expression enables precise control over engineered CAR T cell function. Commun. Biol. 6, 604 (2023).","journal-title":"Commun. Biol."},{"key":"1464_CR148","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1002\/bit.28770","volume":"121","author":"S Galvan","year":"2024","unstructured":"Galvan, S., Teixeira, A. P. & Fussenegger, M. Enhancing cell-based therapies with synthetic gene circuits responsive to molecular stimuli. Biotechnol. Bioeng. 121, 2987\u20133000 (2024).","journal-title":"Biotechnol. Bioeng."},{"key":"1464_CR149","doi-asserted-by":"publisher","first-page":"1425529","DOI":"10.3389\/fbioe.2024.1425529","volume":"12","author":"DC Carneiro","year":"2024","unstructured":"Carneiro, D. C., Rocha, V. P. C., Damasceno, P. K. F., Barbosa, J. D. V. & Soares, M. B. P. Therapeutic applications of synthetic gene\/genetic circuits: a patent review. Front. Bioeng. Biotechnol. 12, 1425529 (2024).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"1464_CR150","doi-asserted-by":"publisher","first-page":"1545270","DOI":"10.3389\/fimmu.2025.1545270","volume":"16","author":"M Shirzadian","year":"2025","unstructured":"Shirzadian, M., Moori, S., Rabbani, R. & Rahbarizadeh, F. SynNotch CAR-T cell, when synthetic biology and immunology meet again. Front. Immunol. 16, 1545270 (2025).","journal-title":"Front. Immunol."},{"key":"1464_CR151","doi-asserted-by":"publisher","unstructured":"Sheehan, P. W. et al. A glial circadian gene expression atlas reveals cell-type and disease-specific reprogramming in response to amyloid pathology or aging. Nat. Neurosci. https:\/\/doi.org\/10.1038\/s41593-025-02067-1 (2025).","DOI":"10.1038\/s41593-025-02067-1"},{"key":"1464_CR152","doi-asserted-by":"publisher","first-page":"e201159","DOI":"10.1172\/jci.insight.201159","volume":"11","author":"PG Lyons","year":"2026","unstructured":"Lyons, P. G. et al. Diurnal rhythm in chimeric antigen receptor T cell effectiveness in an observational study of 715 patients. JCI Insight 11, e201159 (2026).","journal-title":"JCI Insight"},{"key":"1464_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56584-5","volume":"16","author":"L Pferdehirt","year":"2025","unstructured":"Pferdehirt, L. et al. A synthetic chronogenetic gene circuit for programmed circadian drug delivery. Nat. Commun. 16, 1457 (2025).","journal-title":"Nat. Commun."},{"key":"1464_CR154","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3724\/abbs.2025203","volume":"58","author":"X Sun","year":"2026","unstructured":"Sun, X., Qin, L., Liang, X. & Wang, D. Circadian rhythm in immunotherapy and cellular therapy: impacts on the tumor microenvironment. Acta Biochim Biophys. Sin. 58, 90\u2013105 (2026).","journal-title":"Acta Biochim Biophys. Sin."},{"key":"1464_CR155","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/07487304231213916","volume":"39","author":"C Mangini","year":"2024","unstructured":"Mangini, C. et al. Managing circadian disruption due to hospitalization: A pilot randomized controlled trial of the circadiancare inpatient management system. J. Biol. Rhythms 39, 183\u2013199 (2024).","journal-title":"J. Biol. Rhythms"},{"key":"1464_CR156","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev-pharmtox-051920-095416","volume":"64","author":"FA L\u00e9vi","year":"2024","unstructured":"L\u00e9vi, F. A., Okyar, A., Hadadi, E., Innominato, P. F. & Ballesta, A. Circadian regulation of drug responses: toward sex-specific and personalized chronotherapy. Annu. Rev. Pharmacol. Toxicol. 64, 89\u2013114 (2024).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"1464_CR157","doi-asserted-by":"publisher","unstructured":"Bautista, J. et al. Gut microbiome-driven colorectal cancer via immune, metabolic, neural, and endocrine axes reprogramming. npj Biofilms Microbiomes. https:\/\/doi.org\/10.1038\/s41522-025-00883-8 (2026).","DOI":"10.1038\/s41522-025-00883-8"},{"key":"1464_CR158","doi-asserted-by":"publisher","first-page":"1766052","DOI":"10.3389\/fmed.2026.1766052","volume":"13","author":"J Bautista","year":"2026","unstructured":"Bautista, J., Corti\u00f1as Sardi, P., Paguay-Caisabanda, I., Gancino, K. & L\u00f3pez-Cort\u00e9s, A. Integrating microbiome insights into cervical cancer. Front. Med. 13, 1766052 (2026).","journal-title":"Front. Med."},{"key":"1464_CR159","doi-asserted-by":"publisher","first-page":"1654792","DOI":"10.3389\/fmed.2025.1654792","volume":"12","author":"J Bautista","year":"2025","unstructured":"Bautista, J., Fuentes-Y\u00e9pez, M. P., Adatty-Molina, J. & L\u00f3pez-Cort\u00e9s, A. Microbial signatures in metastatic cancer. Front. Med. 12, 1654792 (2025).","journal-title":"Front. Med."},{"key":"1464_CR160","doi-asserted-by":"publisher","first-page":"1737582","DOI":"10.3389\/fmed.2026.1737582","volume":"13","author":"J Bautista","year":"2026","unstructured":"Bautista, J. et al. Decoding the microbial blueprint of pancreatic cancer. Front. Med 13, 1737582 (2026).","journal-title":"Front. Med"},{"key":"1464_CR161","doi-asserted-by":"publisher","first-page":"e002737","DOI":"10.1136\/jitc-2021-002737","volume":"9","author":"JT Huckaby","year":"2021","unstructured":"Huckaby, J. T. et al. Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells. J. Immunother. Cancer 9, e002737 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"1464_CR162","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/mt.2015.234","volume":"24","author":"X Zhou","year":"2016","unstructured":"Zhou, X. et al. Serial activation of the inducible caspase 9 safety switch after human stem cell transplantation. Mol. Ther. 24, 823\u2013831 (2016).","journal-title":"Mol. Ther."},{"key":"1464_CR163","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.cell.2018.03.038","volume":"173","author":"JH Cho","year":"2018","unstructured":"Cho, J. H., Collins, J. J. & Wong, W. W. Universal chimeric antigen receptors for multiplexed and logical control of T cell responses. Cell 173, 1426\u20131438.e11 (2018).","journal-title":"Cell"},{"key":"1464_CR164","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/cts.12636","volume":"12","author":"D Hardiansyah","year":"2019","unstructured":"Hardiansyah, D. & Ng, C. M. Quantitative systems pharmacology model of chimeric antigen receptor T-cell therapy. Clin. Transl. Sci. 12, 343\u2013349 (2019).","journal-title":"Clin. Transl. Sci."},{"key":"1464_CR165","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1182\/blood-2017-06-793141","volume":"130","author":"KA Hay","year":"2017","unstructured":"Hay, K. A. et al. Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy. Blood 130, 2295\u20132306 (2017).","journal-title":"Blood"},{"key":"1464_CR166","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.molmed.2016.03.004","volume":"22","author":"R Dallmann","year":"2016","unstructured":"Dallmann, R., Okyar, A. & L\u00e9vi, F. Dosing-time makes the poison: circadian regulation and pharmacotherapy. Trends Mol. Med. 22, 430\u2013445 (2016).","journal-title":"Trends Mol. Med."},{"key":"1464_CR167","doi-asserted-by":"publisher","first-page":"E1402","DOI":"10.1073\/pnas.1516953113","volume":"113","author":"CJ Morris","year":"2016","unstructured":"Morris, C. J., Purvis, T. E., Hu, K. & Scheer, F. A. J. L. Circadian misalignment increases cardiovascular disease risk factors in humans. Proc. Natl. Acad. Sci. USA 113, E1402\u2013E1411 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01464-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01464-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01464-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:02:26Z","timestamp":1785110546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01464-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":167,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1464"],"URL":"https:\/\/doi.org\/10.1038\/s41698-026-01464-4","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"3 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"290"}}